Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Control Governance: Regulatory Bodies and Their Impact
Prescription, Nonprescription and Orphan Drugs
Drug Regulation
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Robert M Califf1,2, Andrew Slavitt3
1Duke Forge, Duke University School of Medicine, Durham, North Carolina.
No abstract available in PubMed .